Latest news
Loading news…
Eyevance Pharmaceuticals
ClosedOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 MediumHeat score — how much recent activity & attention the company has (web traffic, news, hiring). Fort Worth, Texas, United States Founded 2017 51-100 employees For Profit
Eyevance is a provider of ophthalmic products and therapies intended to address unmet medical needs.
Eyevance Pharmaceuticals was acquired by Santen Pharmaceutical in 2020.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
28
Patents
1
1 trademarks
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 3
- Patents granted
- 1
- Trademarks
- 1
- Top patent class
- Medical Or Veterinary Science; Hygiene
- IT spend
- $8.82M
Company Info
- Founded
- 2017
- Employees
- 51-100
- Operating status
- Closed
- Company type
- For Profit
- Org types
- company
- Founders
- 2
- News articles
- 3
- HQ
- Fort Worth, Texas, United States
- Region
- Dallas/Fort Worth Metroplex, Southern US
- Exit date
- Sep 1, 2020
Signals & Scores
- Heat score
- Medium
- Trend (7d)
- 0
- Trend (30d)
- 0
- Trend (90d)
- -0.5
28
professional contacts at Eyevance Pharmaceuticals
Contact execs at Eyevance Pharmaceuticals →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Eyevance Pharmaceuticals
Loading news…
FAQs about Eyevance Pharmaceuticals
People who checked this page also checked these
Browse the full Acquirezy directory.